news all in one

  Budget 2023: Along with all the expenses, the insurance premiums are also increasing. In this context, the common people are hoping to give some incentives on insurance schemes in the upcoming budget. Insurance related expenses have become crucial in the family budget of individual taxpayers. In the background of high inflation and rising medical expenses, the common man is expecting insurance-related relief from the new budget (Budget 2023) to be presented by Nirmala Sitharaman on February 1. The insurance industry also wants to provide benefits to the common man. It is said that as a result the industry will grow and insurance schemes will be available to all. Section 80D limit increase: At present, persons below the age of 60 can claim tax exemption on health insurance premiums paid for themselves, their spouse, dependent children or parents under Section 80D of the Income Tax Act, 1961. A tax deduction can be availed on premium payments of Rs.25,000 per financial year...

  Sun Pharmaceutical said it will acquire U.S.-based Concert Pharmaceuticals for an upfront payment of $8 per share of common stock in cash, or $576 million in equity value to gain access to an experimental drug for treating patchy baldness. “Sun Pharma is building a global dermatology and ophthalmology franchise and aims to be a preferred development and commercial partner in these therapies worldwide,” said Abhay Gandhi, CEO North America, Sun Pharma. “The acquisition of Concert adds a late-stage, potential best-in-class treatment for Alopecia Areata [patchy baldness) in deuruxolitinib [medication],” he added. Concert’s lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patchy hair loss. Concert stockholders will also receive a non-tradeable contingent value right (CVR), entitling holders to receive up to an additional $3.50 per share of common stock in cash, payable upon deuruxolitinib achieving...